Published in Pharmaceutics on March 14, 2013
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med (2010) 4.32
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf (2002) 4.15
Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf (2009) 3.96
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership. Stat Med (2012) 3.26
Developing the Sentinel System--a national resource for evidence development. N Engl J Med (2011) 2.93
The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf (2010) 2.57
Novel data-mining methodologies for adverse drug event discovery and analysis. Clin Pharmacol Ther (2012) 2.56
Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiol Drug Saf (2010) 2.29
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods. Med Care (2012) 1.82
Multicenter epidemiologic and health services research on therapeutics in the HMO Research Network Center for Education and Research on Therapeutics. Pharmacoepidemiol Drug Saf (2002) 1.79
The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf (2012) 1.73
Managing drug-risk information--what to do with all those new numbers. N Engl J Med (2009) 1.49
Safety surveillance of longitudinal databases: methodological considerations. Pharmacoepidemiol Drug Saf (2011) 1.48
Disproportionality analysis using empirical Bayes data mining: a tool for the evaluation of drug interactions in the post-marketing setting. Pharmacoepidemiol Drug Saf (2003) 1.41
The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts. Drug Saf (1998) 1.25
Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med (2005) 1.23
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics (2011) 1.20
Disproportionality methods for pharmacovigilance in longitudinal observational databases. Stat Methods Med Res (2011) 1.14
Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf (2005) 1.10
A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf (2008) 1.09
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf (2007) 1.04
Mining unexpected temporal associations: applications in detecting adverse drug reactions. IEEE Trans Inf Technol Biomed (2008) 1.03
Terbinafine-induced hepatic failure requiring liver transplantation. Liver Transpl (2007) 1.02
Adaptation of Bayesian data mining algorithms to longitudinal claims data: coxib safety as an example. Med Care (2008) 0.91
A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiol Drug Saf (2011) 0.91
Fungal arthritis and osteomyelitis. Infect Dis Clin North Am (2005) 0.91
Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc (2005) 0.90
Acute generalized exanthematous pustulosis induced by itraconazole: an immunological approach. Clin Exp Dermatol (2009) 0.89
A tree-based scan statistic for database disease surveillance. Biometrics (2003) 0.89
Signal detection for vaccine side effects that have not been specified in advance. Pharmacoepidemiol Drug Saf (2010) 0.88
Active influenza vaccine safety surveillance: potential within a healthcare claims environment. Med Care (2009) 0.86
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis. Ann Pharmacother (2008) 0.86
Differential association between statin exposure and elevated levels of creatine kinase. Ann Pharmacother (2005) 0.81
Increasing scientific standards, independence and transparency in post-authorisation studies: the role of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiol Drug Saf (2012) 0.81
Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf (2013) 0.79
Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature. Am J Clin Dermatol (2006) 0.77
Safety surveillance of longitudinal databases: further methodological considerations. Pharmacoepidemiol Drug Saf (2012) 0.77
Terminological challenges in safety surveillance. Drug Saf (2012) 0.77
Hepatic failure related to itraconazole use successfully treated by corticosteroids. Hepat Mon (2011) 0.76
Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002) 10.48
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18
Syndromic surveillance in public health practice, New York City. Emerg Infect Dis (2004) 6.16
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25
Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf (2006) 5.16
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol (2009) 5.11
Prescription drug use in pregnancy. Am J Obstet Gynecol (2004) 4.92
SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab (2007) 4.75
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother (2006) 4.28
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med (2006) 3.96
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87
De facto long-term opioid therapy for noncancer pain. Clin J Pain (2008) 3.85
Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83
Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerg Infect Dis (2002) 3.79
Dead bird clusters as an early warning system for West Nile virus activity. Emerg Infect Dis (2003) 3.75
Health plan members' views about disclosure of medical errors. Ann Intern Med (2004) 3.69
Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics (2006) 3.61
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res (2009) 3.39
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ (2011) 3.29
Power evaluation of disease clustering tests. Int J Health Geogr (2003) 3.26
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet (2005) 3.18
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. Lancet Oncol (2013) 3.11
Outcomes of prenatal antidepressant exposure. Am J Psychiatry (2002) 3.07
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf (2002) 2.98
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res (2004) 2.96
Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol (2007) 2.93
A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care (2012) 2.92
Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy (2008) 2.82
Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo. J Clin Invest (2007) 2.80
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73
The new Sentinel Network--improving the evidence of medical-product safety. N Engl J Med (2009) 2.73
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology (2012) 2.63
Temporal competition between differentiation programs determines cell fate choice. Mol Syst Biol (2011) 2.61
Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol (2007) 2.61
The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60
Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf (2012) 2.41
Effects of a law against early postpartum discharge on newborn follow-up, adverse events, and HMO expenditures. N Engl J Med (2002) 2.41
Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med (2014) 2.41
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics (2010) 2.39
Effect of quality improvement on racial disparities in diabetes care. Arch Intern Med (2006) 2.36
Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care (2006) 2.28
Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27
Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy (2010) 2.25
Chronic use of opioid medications before and after bariatric surgery. JAMA (2013) 2.25
Platelet calmodulin levels in adolescent idiopathic scoliosis: do the levels correlate with curve progression and severity? Spine (Phila Pa 1976) (2002) 2.24
The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2012) 2.22
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening: a randomized controlled trial. Arch Intern Med (2010) 2.21
Potential medication dosing errors in outpatient pediatrics. J Pediatr (2005) 2.19
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16
The misdiagnosis of epilepsy. BMJ (2002) 2.16
Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health (2010) 2.13
Rates of concussion are lower in National Football League games played at higher altitudes. J Orthop Sports Phys Ther (2014) 2.11
Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain (2009) 2.09
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf (2007) 2.09
Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning. Mol Ther (2006) 2.08
Effect of Iyengar yoga therapy for chronic low back pain. Pain (2005) 2.04
Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03
Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment. J Manag Care Spec Pharm (2014) 2.03
Risk of myocardial infarction with combination antihypertensive regimens including a dihydropyridine calcium channel blocker in hypertensive diabetics. J Manag Care Pharm (2003) 2.03
Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis (2007) 2.03
Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. Med Image Comput Comput Assist Interv (2006) 2.00
A critical review of methods to evaluate the impact of FDA regulatory actions. Pharmacoepidemiol Drug Saf (2013) 2.00
Race differences in long-term diabetes management in an HMO. Diabetes Care (2005) 1.98
A WAVE-1 and WRP signaling complex regulates spine density, synaptic plasticity, and memory. J Neurosci (2007) 1.97
Loss of AKAP150 perturbs distinct neuronal processes in mice. Proc Natl Acad Sci U S A (2008) 1.96
Genome-wide association mapping to candidate polymorphism resolution in the unsequenced barley genome. Proc Natl Acad Sci U S A (2010) 1.96
Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol (2008) 1.96
A spatial scan statistic for survival data. Biometrics (2007) 1.95